U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
DOJ Rescinds Anti-Weaponization Fund Ahead of Todd Blanche Senate Confirmation Vote
US-Backed Venezuela Government, Opposition Talks Begin
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Abdul El-Sayed Wins Michigan Democratic Senate Primary, Sets Up Key Midterm Showdown
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
AI Data Center Boom Faces New Risks as Public Backlash and Policy Scrutiny Grow
Taiwan President Lai Oversees Coastal Strike Drills in Han Kuang War Games
ICE to Complete Nationwide Body Camera Rollout by End of August
Trump Administration Weighs Executive Order on Vaccines and Autism Research
Germany Warns of Daily Hybrid Warfare Threats
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 



